88 related articles for article (PubMed ID: 26922015)
1. [Role of SIRT3 in regulating proliferation of hepatocellular carcinoma cells in vitro].
Tao Y; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):195-9. PubMed ID: 26922015
[TBL] [Abstract][Full Text] [Related]
2. Modulation of SIRT3 expression through CDK4/6 enhances the anti-cancer effect of sorafenib in hepatocellular carcinoma cells.
Jo H; Park Y; Kim T; Kim J; Lee JS; Kim SY; Chung JI; Ko HY; Pyun JC; Kim KS; Lee M; Yun M
BMC Cancer; 2020 Apr; 20(1):332. PubMed ID: 32306906
[TBL] [Abstract][Full Text] [Related]
3. Sirtuin 3 enhanced drug sensitivity of human hepatoma cells through glutathione S-transferase pi 1/JNK signaling pathway.
Tao NN; Zhou HZ; Tang H; Cai XF; Zhang WL; Ren JH; Zhou L; Chen X; Chen K; Li WY; Liu B; Yang QX; Cheng ST; Huang LX; Huang AL; Chen J
Oncotarget; 2016 Aug; 7(31):50117-50130. PubMed ID: 27367026
[TBL] [Abstract][Full Text] [Related]
4. Sirtuin 3 inhibits hepatocellular carcinoma growth through the glycogen synthase kinase-3β/BCL2-associated X protein-dependent apoptotic pathway.
Song CL; Tang H; Ran LK; Ko BC; Zhang ZZ; Chen X; Ren JH; Tao NN; Li WY; Huang AL; Chen J
Oncogene; 2016 Feb; 35(5):631-41. PubMed ID: 25915842
[TBL] [Abstract][Full Text] [Related]
5. {2-[1-(3-Methoxycarbonylmethyl-1H-indol-2-yl)-1-methyl-ethyl]-1H-indol-3-yl}-acetic acid methyl ester (MIAM) inhibited human hepatocellular carcinoma growth through upregulation of Sirtuin-3 (SIRT3).
Li Y; Wang W; Xu X; Sun S; Qu XJ
Biomed Pharmacother; 2015 Feb; 69():125-32. PubMed ID: 25661348
[TBL] [Abstract][Full Text] [Related]
6. SIRT3 expression in hepatocellular carcinoma and its impact on proliferation and invasion of hepatoma cells.
Zhang B; Qin L; Zhou CJ; Liu YL; Qian HX; He SB
Asian Pac J Trop Med; 2013 Aug; 6(8):649-52. PubMed ID: 23790338
[TBL] [Abstract][Full Text] [Related]
7. The expression of SIRT3 in primary hepatocellular carcinoma and the mechanism of its tumor suppressing effects.
Liu Y; Liu YL; Cheng W; Yin XM; Jiang B
Eur Rev Med Pharmacol Sci; 2017 Mar; 21(5):978-998. PubMed ID: 28338198
[TBL] [Abstract][Full Text] [Related]
8. Sirt3 inhibits hepatocellular carcinoma cell growth through reducing Mdm2-mediated p53 degradation.
Zhang YY; Zhou LM
Biochem Biophys Res Commun; 2012 Jun; 423(1):26-31. PubMed ID: 22609775
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of the long non-coding RNA SPRY4-IT1 promotes tumor cell proliferation and invasion by activating EZH2 in hepatocellular carcinoma.
Zhou M; Zhang XY; Yu X
Biomed Pharmacother; 2017 Jan; 85():348-354. PubMed ID: 27899259
[TBL] [Abstract][Full Text] [Related]
10. [Inhibitory effect of blocking expression of human augmenter of liver regeneration (hALR) on proliferation of hepatocellular carcinoma cell line HepG2].
Tang L; Sun H; Zhang L; Guo H; Zhang L; Liu Q
Ai Zheng; 2006 Jun; 25(6):671-6. PubMed ID: 16764759
[TBL] [Abstract][Full Text] [Related]
11. SIRT3 suppression resulting from the enhanced β-catenin signaling drives glycolysis and promotes hypoxia-induced cell growth in hepatocellular carcinoma cells.
Ma R; Gao QY; Chen ZT; Liao GH; Li ST; Cai JW; Luo NS; Chen H; Zhang HF
Cell Cycle; 2024 Feb; 23(4):435-447. PubMed ID: 38626328
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of connective tissue growth factor overexpression decreases growth of hepatocellular carcinoma cells in vitro and in vivo.
Jia XQ; Cheng HQ; Li H; Zhu Y; Li YH; Feng ZQ; Zhang JP
Chin Med J (Engl); 2011 Nov; 124(22):3794-9. PubMed ID: 22340243
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of Protein Phosphatase 1γ (PP1γ) Is Associated with Enhanced Cell Proliferation and Poor Prognosis in Hepatocellular Carcinoma.
Li C; Wu M; Zong G; Wan C; Liu Q; Zhou H; Hua L; Chen Y; Chen X; Lu C
Dig Dis Sci; 2017 Jan; 62(1):133-142. PubMed ID: 27921263
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of SMYD3 gene expression by RNA interference induces apoptosis in human hepatocellular carcinoma cell line HepG2].
Xu JY; Chen LB; Xu JY; Yang Z; Wei HY; Xu RH
Ai Zheng; 2006 May; 25(5):526-32. PubMed ID: 16687068
[TBL] [Abstract][Full Text] [Related]
15. [The effects of microRNA-7 on proliferation and invasion of hepatocellular carcinoma HepG2 cells].
Qin AD; Liu XX; Li J; Liu J; Li YS
Zhonghua Zhong Liu Za Zhi; 2018 Jun; 40(6):406-411. PubMed ID: 29936764
[No Abstract] [Full Text] [Related]
16. Decreased STAT4 indicates poor prognosis and enhanced cell proliferation in hepatocellular carcinoma.
Wang G; Chen JH; Qiang Y; Wang DZ; Chen Z
World J Gastroenterol; 2015 Apr; 21(13):3983-93. PubMed ID: 25852285
[TBL] [Abstract][Full Text] [Related]
17. [Interferon-induced transmembrane protein 3 knock-down inhibits proliferation and invasion of hepatocellular carcinoma HepG2 cells in vitro].
Wu RS; Wu LQ; Li KH; Li EL; Feng Q; Zhang JL
Nan Fang Yi Ke Da Xue Xue Bao; 2016 Feb; 36(2):244-9. PubMed ID: 26922024
[TBL] [Abstract][Full Text] [Related]
18. Potential roles of EZH2, Bmi-1 and miR-203 in cell proliferation and invasion in hepatocellular carcinoma cell line Hep3B.
Yang F; Lv LZ; Cai QC; Jiang Y
World J Gastroenterol; 2015 Dec; 21(47):13268-76. PubMed ID: 26715809
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of WWP1 promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma.
Zhang XF; Chao J; Pan QZ; Pan K; Weng DS; Wang QJ; Zhao JJ; He J; Liu Q; Jiang SS; Chen CL; Zhang HX; Xia JC
Oncotarget; 2015 Dec; 6(38):40920-33. PubMed ID: 26506518
[TBL] [Abstract][Full Text] [Related]
20. [Interference of osteopontin expression inhibits the invasion and metastasis of human hepatocellular carcinoma cell lines].
Lin F; Li YY; Xia JT; Wen MJ; Lai YY; Cai WS; Wu ZF; Fan SF
Zhonghua Gan Zang Bing Za Zhi; 2009 Jun; 17(6):422-5. PubMed ID: 19567019
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
